Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease

J. Neurochem. (2010) 112, 1539-1551. To investigate the role of the Wnt inhibitor Dickkopf-1 (DKK-1) in the pathophysiology of neurodegenerative diseases, we analysed DKK-1 expression and localization in transgenic mouse models expressing familial Alzheimer's disease mutations and a frontotempo...

Full description

Saved in:
Bibliographic Details
Published inJournal of neurochemistry Vol. 112; no. 6; pp. 1539 - 1551
Main Authors Rosi, Maria Cristina, Luccarini, Ilaria, Grossi, Cristina, Fiorentini, Anna, Spillantini, Maria Grazia, Prisco, Antonella, Scali, Carla, Gianfriddo, Marco, Caricasole, Andrea, Terstappen, Georg C, Casamenti, Fiorella
Format Journal Article
LanguageEnglish
Published Oxford, UK Oxford, UK : Blackwell Publishing Ltd 01.03.2010
Blackwell Publishing Ltd
Wiley-Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:J. Neurochem. (2010) 112, 1539-1551. To investigate the role of the Wnt inhibitor Dickkopf-1 (DKK-1) in the pathophysiology of neurodegenerative diseases, we analysed DKK-1 expression and localization in transgenic mouse models expressing familial Alzheimer's disease mutations and a frontotemporal dementia mutation. A significant increase of DKK-1 expression was found in the diseased brain areas of all transgenic lines, where it co-localized with hyperphosphorylated tau-bearing neurons. In TgCRND8 mice, DKK-1 immunoreactivity was detected in neurons surrounding amyloid deposits and within the choline acetyltransferase-positive neurons of the basal forebrain. Active glycogen synthase kinase-3 (GSK-3) was found to co-localize with DKK-1 and phospho-tau staining. Downstream to GSK-3, a significant reduction in β-catenin translocation to the nucleus, indicative of impaired Wnt signaling functions, was found as well. Cumulatively, our findings indicate that DKK-1 expression is associated with events that lead to neuronal death in neurodegenerative diseases and support a role for DKK-1 as a key mediator of neurodegeneration with therapeutic potential.
Bibliography:http://dx.doi.org/10.1111/j.1471-4159.2009.06566.x
Maria Cristina Rosi and Ilaria Luccarini were equally involved in the study.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-3042
1471-4159
DOI:10.1111/j.1471-4159.2009.06566.x